World news, news around town, tech update 3
Ad
Tuesday, 27 June 2017
Israel's Mitoconix Bio raises $20 million in private funding round
JERUSALEM (Reuters) - Mitoconix Bio, an Israeli biopharmaceutical company focused on treating neurological diseases, said on Tuesday it raised $20 million in an early funding round.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment